Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples

Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples

Testing for high-risk human papillomavirus (HPV) as part of primary cervical cancer screening has become more common recently. The Cobas 6800, an FDA-approved cervical screening platform, detects 14 high-risk HPVs, including HPV16 and HPV18. However, this test is limited to only women, which leads t...

Full description

Bibliographic Details
Main Authors: Brian Joseph Hajjar, Ummar Raheel, Rachel Manina, Jovanie Simpson, Muhammad Irfan, Yasir Waheed
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Vaccines
Subjects:
HPV
cervical cancer
Cobas 6800
urine testing
gender-neutral screening
Online Access:https://www.mdpi.com/2076-393X/11/6/1071

Internet

https://www.mdpi.com/2076-393X/11/6/1071

Similar Items